It was found that the number of CD169+ macrophages in tumor tissues was significantly less than that in adjacent normal tissues, and patients with large numbers of CD169+ macrophages in tumor tissues had a better clinical prognosis [39, 40]. Here, SIGLEC1 is linked to neoplasm.